Načítá se...
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Cystic fibrosis (CF) is a complex genetic disease characterized by death from loss of lung function. Therapies target pathophysiologic changes associated with pulmonary disease progression. Although therapeutic mechanisms differ, efficacy demonstration is limited to a few accepted outcome measures,...
Uloženo v:
| Vydáno v: | Clin Investig (Lond) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486293/ https://ncbi.nlm.nih.gov/pubmed/26146539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/cli.11.174 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|